ImmuCell Corporation
ICCC
$9.89
-$0.02-0.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.51% | 168.15% | -1,939.44% | -127.83% | -65.31% |
| Total Depreciation and Amortization | -10.92% | -25.20% | 4.01% | 1.63% | -1.15% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | -89.19% | 174.07% | 0.00% |
| Total Other Non-Cash Items | 69.10% | -94.58% | 3,163.93% | -545.19% | 8.90% |
| Change in Net Operating Assets | -52.37% | 540.09% | 87.04% | -514.93% | 169.05% |
| Cash from Operations | -15.50% | 640.52% | 140.80% | -173.84% | 1.76% |
| Capital Expenditure | -314.16% | -2.84% | 70.99% | -282.67% | 52.84% |
| Sale of Property, Plant, and Equipment | -100.00% | 100.00% | 163.16% | -93.49% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -338.94% | 0.06% | 71.74% | -370.21% | 61.74% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -0.63% | -1.37% | 64.90% | -194.78% | -0.34% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | 1,600.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 41.37% | 42.09% |
| Cash from Financing | 40.60% | -1.37% | -16.85% | -342.02% | 81.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.88% | 3,885.64% | 96.24% | -250.98% | 66.34% |